Table 3.
Comparison of clinical parameters of participants diagnosed with MAFLD and NAFLD in CPOOA by ultrasound.
| Variables | Based on the MAFLD/NAFLD Criteria (N = 1026) | ||
|---|---|---|---|
| Non-MAFLD/NAFLD (N = 864) | MAFLD/NAFLD (N = 162) | p | |
| Age (years) | 11.44 ± 0.11 | 11.81 ± 0.17 | 0.128 |
| Male (%) | 53.1 | 71.0 | <0.001 |
| BMI-z | 0.97 ± 0.04 | 3.13 ± 0.11 | <0.001 |
| T2DM | 0.2 | 1.2 | 0.120 |
| Hypertension | 6.1 | 17.9 | <0.001 |
| ALT (U/L) | 12.95 ± 0.41 | 26.90 ± 2.41 | <0.001 |
| FPG (mmol/L) | 5.34 ± 0.01 | 5.48 ± 0.03 | <0.001 |
| TC (mmol/L) | 4.09 ± 0.01 | 4.23 ± 0.06 | 0.021 |
| TG (mmol/L) | 0.87 ± 0.12 | 1.17 ± 0.04 | <0.001 |
| LDL-C (mmol/L) | 2.17 ± 0.02 | 2.50 ± 0.05 | <0.001 |
| HDL-C (mmol/L) | 1.54 ± 0.01 | 1.36 ± 0.02 | <0.001 |
Continuous values are means ± SEs, and categorical variables are numbers and weighted proportions. We used a t-test and the Rao–Scott chi-squared test to compare the differences between groups. MAFLD: metabolic-associated fatty liver disease; NAFLD: nonalcoholic fatty liver disease; T2DM: type 2 diabetes mellitus; CPOOA: Comprehensive Prevention Project for Overweight and Obese Adolescents.